143 related articles for article (PubMed ID: 18334011)
1. Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.
Wu W; Celestino J; Milam MR; Schmeler KM; Broaddus RR; Ellenson LH; Lu KH
Int J Gynecol Cancer; 2008; 18(2):329-38. PubMed ID: 18334011
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Cao LQ; Chen XL; Wang Q; Huang XH; Zhen MC; Zhang LJ; Li W; Bi J
Acta Pharmacol Sin; 2007 Jun; 28(6):879-87. PubMed ID: 17506947
[TBL] [Abstract][Full Text] [Related]
3. PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats.
Efrati S; Berman S; Ilgiyeav E; Averbukh Z; Weissgarten J
Nephron Exp Nephrol; 2007; 106(4):e107-12. PubMed ID: 17622738
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
[TBL] [Abstract][Full Text] [Related]
5. Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.
Milam MR; Celestino J; Wu W; Broaddus RR; Schmeler KM; Slomovitz BM; Soliman PT; Gershenson DM; Wang H; Ellenson LH; Lu KH
Am J Obstet Gynecol; 2007 Mar; 196(3):247.e1-5. PubMed ID: 17346540
[TBL] [Abstract][Full Text] [Related]
6. PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression.
Lee SY; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Lung Cancer; 2006 Mar; 51(3):297-301. PubMed ID: 16386327
[TBL] [Abstract][Full Text] [Related]
7. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
Xiao L; Yang YB; Shen HM; Xu CF; Wang XY; Li XM
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.
Sun WH; Chen GS; Ou XL; Yang Y; Luo C; Zhang Y; Shao Y; Xu HC; Xiao B; Xue YP; Zhou SM; Zhao QS; Ding GX
Cancer Lett; 2009 Mar; 275(2):247-55. PubMed ID: 19056168
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells.
Lee SY; Kang EJ; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; In KH; Kang KH; Yoo SH; Shim JJ
Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L84-90. PubMed ID: 16443643
[TBL] [Abstract][Full Text] [Related]
10. Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo.
Dai Y; Qiao L; Chan KW; Zou B; Ma J; Lan HY; Gu Q; Li Z; Wang Y; Wong BL; Wong BC
Int J Cancer; 2008 Jun; 122(12):2858-63. PubMed ID: 18351648
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone prevents graft-versus-host disease (GVHD).
Song EK; Yim JM; Yim JY; Song MY; Rho HW; Yim SK; Jeon SY; Kim HS; Yhim HY; Lee NR; Kwak JY; Sohn MH; Park HS; Jang KY; Yim CY
Transpl Immunol; 2012 Oct; 27(2-3):128-37. PubMed ID: 22982856
[TBL] [Abstract][Full Text] [Related]
12. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
14. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
15. The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model.
Krieger-Hinck N; Schumacher U; Müller A; Valentiner U
Oncol Res; 2010; 18(8):387-93. PubMed ID: 20441053
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN.
Lin CF; Young KC; Bai CH; Yu BC; Ma CT; Chien YC; Chiang CL; Liao CS; Lai HW; Tsao CW
Biomed Res Int; 2014; 2014():787924. PubMed ID: 24757676
[TBL] [Abstract][Full Text] [Related]
17. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells.
Kim KY; Kim SS; Cheon HG
Biochem Pharmacol; 2006 Aug; 72(5):530-40. PubMed ID: 16806087
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
Gunin AG; Bitter AD; Demakov AB; Vasilieva EN; Suslonova NV
J Endocrinol; 2004 Aug; 182(2):229-39. PubMed ID: 15283683
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
Zhang CH; Wen ZQ; Li JF; Li CZ; Shi M; Yang GW; Lan SM; Zhu Y; Wang F; Zhang YJ; Wang YY; Zhang H
Chin Med J (Engl); 2008 Jan; 121(2):166-71. PubMed ID: 18272045
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM
Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
